Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1
Hyperthermia and protein homeostasis: Cytoprotection and cell death
Ex vivo pulsed dendritic cell vaccination against cancer
Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?
Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial
Curcumin effect on cancer cells‘ multidrug resistance: An update
Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial
Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment
A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 conventional dendritic cells
Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients
Dendritic cell therapy in cancer treatment; the state-of-the-art
The function and clinical application of extracellular vesicles in innate immune regulation
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
Prof. Dr. Volker Schirrmacher veröffentlicht zwei wegweisende Übersichtsartikel zur Immuntherapie
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis
Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?